BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry-Reference-Cited by-同舟云学术

BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry

Published:2022-10-31 Issue:1 Volume:356 Page:2200371
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Archiv der Pharmazie

Author:

Moumbock Aurélien F. A.¹^ORCID,Tran Hoai T. T.²,Lamy Evelyn²,Günther Stefan¹^ORCID

Affiliation:

1. Faculty of Chemistry and Pharmacy, Institute of Pharmaceutical Sciences Albert‐Ludwigs‐Universität Freiburg Freiburg Germany

2. Molecular Preventive Medicine, Faculty of Medicine University Medical Center, Albert‐Ludwigs‐Universität Freiburg Freiburg Germany

Funder

Deutscher Akademischer Austauschdienst

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202200371

Reference31 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. World Health Organization (WHO).Weekly Epidemiological Update on COVID‐19. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-march-2022

3. A comparative overview of COVID-19, MERS and SARS: Review article

4. TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

5. The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein binding;The Microbe;2024-06

2. Repurposing and discovery of transmembrane serine protease 2 (TMPRSS2) inhibitors as prophylactic therapies for new coronavirus disease 2019 (COVID-19);PHARMAZIE;2023

3. Structural understanding of SARS-CoV-2 virus entry to host cells;Frontiers in Molecular Biosciences;2023-11-02

4. A Tale of Two Proteases: MPro and TMPRSS2 as Targets for COVID-19 Therapies;Pharmaceuticals;2023-06-02

5. In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases;Viruses;2023-05-15